Conference Interview #23 of 25
Sarah Anwar, MDLinx
San Antonio Breast Cancer Symposium 2017
San Antonio, Texas, United States | December 05-09, 2017
In this study, researchers were able to use dynamic breast MRI texture analysis to determine the heterogeneity of tumor cells. “What’s very interesting in this trial is that MRI features of marked heterogeneity really predicted patients who were at the highest risk for recurrence,” said Dr. Feldman
“In fact,” he continued, “all of the 14 patients in this study who developed recurrence were all of this heterogenous population, which was predicted by this MRI.”